Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M de Gasparo

Showing results (11-20 of 154) with videos related to

Pageof 16
Sort By:
Regulatory Peptides|July 8, 1999
The AT2 receptor: fact, fancy and fantasyM de Gasparo, H M Siragy
Diabetologia|July 1, 1980
The timing of fetal B cell hyperplasia in diabetic rat pregnancyM de Gasparo, R D Milner
Kidney International|December 1, 1994
Pharmacology of angiotensin II receptors in the kidneyM de Gasparo, N R Levens
Ciba Foundation Symposium|January 1, 1981
The autonomic nervous system and perinatal metabolismR D Milner, M De Gasparo
The Journal of Endocrinology|November 1, 1981
Effect of non-essential amino acids on fetal rat pancreatic growth and insulin secretion in vitroR D Milner, M de Gasparo
Annales D'Endocrinologie|November 1, 1971
[Modulation of growth hormone (HGH) secretion by muscular administration of insulin]C J Blum, M de Gasparo
Experimental and Clinical Cardiology|April 30, 2010
Role of the angiotensin II receptor blocker valsartan in heart failureR L Webb, M de Gasparo
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 1, 1984
Role of the adrenals in the development of streptozotocin (STR)-induced diabetes in male albino ratsW Albrecht, M de Gasparo, F Märki
Arzneimittel-Forschung|January 1, 1983
Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 3. Hypoglycemic activity and mode of action of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexyl-2-imino- imidazolidine (CGP 11 112)F Märki, W Albrecht, M de Gasparo
European Journal of Pharmacology|January 14, 1997
Blockade of angiotensin converting enzyme but not of angiotensin AT1 receptors improves glucose toleranceL Chow, M De Gasparo, N Levens
Pageof 16

Showing results (11-20 of 154) with videos related to

Sort By:
Pageof 16
Regulatory Peptides|July 8, 1999
The AT2 receptor: fact, fancy and fantasyM de Gasparo, H M Siragy
Diabetologia|July 1, 1980
The timing of fetal B cell hyperplasia in diabetic rat pregnancyM de Gasparo, R D Milner
Kidney International|December 1, 1994
Pharmacology of angiotensin II receptors in the kidneyM de Gasparo, N R Levens
Ciba Foundation Symposium|January 1, 1981
The autonomic nervous system and perinatal metabolismR D Milner, M De Gasparo
The Journal of Endocrinology|November 1, 1981
Effect of non-essential amino acids on fetal rat pancreatic growth and insulin secretion in vitroR D Milner, M de Gasparo
Annales D'Endocrinologie|November 1, 1971
[Modulation of growth hormone (HGH) secretion by muscular administration of insulin]C J Blum, M de Gasparo
Experimental and Clinical Cardiology|April 30, 2010
Role of the angiotensin II receptor blocker valsartan in heart failureR L Webb, M de Gasparo
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 1, 1984
Role of the adrenals in the development of streptozotocin (STR)-induced diabetes in male albino ratsW Albrecht, M de Gasparo, F Märki
Arzneimittel-Forschung|January 1, 1983
Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 3. Hypoglycemic activity and mode of action of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexyl-2-imino- imidazolidine (CGP 11 112)F Märki, W Albrecht, M de Gasparo
European Journal of Pharmacology|January 14, 1997
Blockade of angiotensin converting enzyme but not of angiotensin AT1 receptors improves glucose toleranceL Chow, M De Gasparo, N Levens
Pageof 16